Clinical Trials Directory

Trials / Completed

CompletedNCT01860248

Vapocoolant Spray Effectiveness On Arterial Puncture Pain: Randomized Double Blind Placebo-Controlled Trial

Topical Alkane Vapocoolant Spray Effectiveness On Arterial Puncture Pain Reduction In Emergency Department: Randomized Double Blind Placebo-Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Tehran University of Medical Sciences · Academic / Other
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

This study was aimed to compare pain levels from arterial blood gas (ABG) sampling performed with vapocoolant spray in comparison to placebo.

Detailed description

Previous studies of vapocoolant sprays for reducing pain were mainly on venopuncture with inconsistent results. There was only one prospective open labeled controlled study on arterial blood gas sampling with ethyl chloride which did not show effectiveness. This study will assess the efficacy and tolerability of a topical alkane vapocoolant spray for arterial puncture in adults in comparison to control spray.

Conditions

Interventions

TypeNameDescription
DRUGVapocoolant sprayThe Vapocoolant spray containing alkane is applied for 20 seconds.
DRUGWater sprayThis spray is covered so the patient and the investigator can not find the spray type out.

Timeline

Start date
2012-05-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2013-05-22
Last updated
2013-07-17

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01860248. Inclusion in this directory is not an endorsement.